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By Tsuneo OMURA*1,†
(Communicated by Masanori OTSUKA, M.J.A.)
Abstract: Since the publication of the ﬁrst paper on “cytochrome P450” in 1962, the
biochemical research on this novel hemoprotein expanded rapidly in the 1960s and the 1970s as its
principal roles in various important metabolic processes including steroid hormone biosynthesis in
the steroidogenic organs and drug metabolism in the liver were elucidated. Establishment of the
puriﬁcation procedures of microsomal and mitochondrial P450s in the middle of the 1970s together
with the introduction of molecular biological techniques accelerated the remarkable expansion of the
research on P450 in the following years. This review paper summarizes the important developments
in the research on P450 in the early years, for about two decades from the beginning, together with
my personal recollections.
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Introduction
The ﬁrst paper on “cytochrome P450” (P450)
was published in 1962.1) It reported the hemoprotein
nature of “microsomal carbon monoxide-binding
pigment” described in 1958.2) In the next year,
1963, the monooxygenase activity of the P450 of
adrenal cortex microsomes was found.3),4) Basic
properties of P450 and its solubilized inactive form,
P420, were reported in 19635) and in 1964.6),7) Based
on these ﬁndings, rapid expansion of the research on
P450 ensued in the following years of the 1960s, and
the research expanded further in the 1970s. Major
subjects of study on the physiological functions of
P450 in the ﬁrst decade of the P450 research were
the biosynthesis of steroid hormones in the adrenal
cortex and the oxidative metabolism of drugs in the
liver.
Puriﬁcation of microsomal and mitochondrial
P450s was achieved in the middle of the 1970s, which
resulted in the identiﬁcation and characterization of
many forms of P450 puriﬁed from animal tissues.
Wide distribution of P450 among various organisms
including plants and microbes also suggested the
presence of many diﬀerent forms of P450 and their
diversiﬁed physiological functions. Studies on the
mechanism of P450-catalyzed oxygenation reactions
indicated the formation of chemically reactive inter-
mediates that can react with proteins and nucleic
acids in the cells, and the principal role of P450 in the
chemical carcinogenesis was recognized by the begin-
ning of the 1970s. Research on P450 expanded into
various ﬁelds of biological and medical sciences in the
1970s, and continued the expansion in the following
years. It has developed into a big research ﬁeld. About
2,000 papers on P450 are now published annually.
The opening of a new research ﬁeld is always
exciting and full of interesting events. I had a
fortunate opportunity to participate in the research
on P450 from the beginning, and have acquainted
with many of the pioneers in this research ﬁeld. This
paper describes important historical events in the
early years of research on P450, for about two
decades from the beginning. Contributions by the
pioneering scientists to the elucidation of various
problems on P450 are highlighted with my personal
recollections.
Heralding events in the 1950s
Two important events in the 1950s, one in cell
biology and another in enzymology, were the
preludes to the discovery of P450. They were the
isolation of microsomes from animal tissues and the
discovery of oxygenase reactions, respectively.
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various distinct subcellular fractions was one of the
most important achievements in the beginning of cell
biology. A novel subcellular fraction named “micro-
somes” by A. Claude in 19438) was isolated from the
homogenates of animal tissues by fractional centri-
fugation, and was identiﬁed to be the fragmented
membrane vesicles of endoplasmic reticulum by G. E.
Palade and P. Siekevitz in 1956.9) Characterization
of microsomes led to the discovery of the presence
of several electron-transport enzymes in this novel
subcellular fraction.
NADH-cytochrome c reductase,10),11) NADPH-
cytochrome c reductase,12) and cytochrome b5
13),14)
were found to be associated with the microsomal
fraction prepared from animal liver. Since the
mitochondrial electron-transport system and oxida-
tive phosphorylation were the hot research subjects
in biochemistry in the 1950s, possible contribution
of these microsmal electron-transport activities to
mitochondrial respiratory system was searched, but
the results were all negative. The physiological
signiﬁcance of the “microsomal electron-transport
system” remained unknown.15) Another redox com-
ponent “carbon monoxide-binding pigment” in liver
microsomes was reported by M. Klingenberg in
1958,2) but the nature of this novel microsomal
component was not clariﬁed.
The oxygenase reaction was conﬁrmed for mush-
room phenolase by H. S. Mason, W. L. Fowlks, and
E. Peterson16) and for Pseudomonas pyrocatechase
by O. Hayaishi, M. Katagiri, and S. Rothberg17) in
1955. The incorporation of atmospheric oxygen
into the substrate molecule in the hydroxylation
of steroids catalyzed by the homogenates of beef
adrenal was also reported in the same year by M.
Hayano et al.18) Introduction of oxygen atom from
atmospheric oxygen into organic compounds was a
remarkable novel enzymatic reaction, and was soon
found to be involved in various important metabolic
activities in animal tissues; metabolism of trypto-
phan,19) biosynthesis of steroid hormones from
cholesterol,18),20) oxidative metabolism of drugs in
the liver,21) etc. The oxygenases involved in the
metabolism of tryptophan were soluble. They were
puriﬁed and characterized. However, the oxygenases
involved in the biosynthesis of steroid hormones
and the oxidative metabolism of drugs were both
associated with membrane fractions, and resisted to
solubilization and puriﬁcation. When the membrane
fractions were treated with detergents to solubilize
these oxygenases, the enzyme activities were always
lost. The nature of these important oxygenases
remained unknown until the discovery of P450.
Discovery and characterization
of cytochrome P450
Presence of a novel carbon monoxide-binding
pigment in liver microsomes was found by M.
Klingenberg in 1954, when he was a postdoctoral
fellow in the laboratory of B. Chance at the
Johnson Research Foundation of the University of
Pennsylvania, Philadelphia. He was a physical
chemist graduated from the University of Heidelberg,
Germany, and came to the Chance’s laboratory in
1954 to study biochemistry. He was instructed by
Chance to examine the oxidation-reduction kinetics
of cytochrome b5 in rat liver microsomes. He reduced
a suspension of rat liver microsomes with sodium
dithionite and bubbled carbon monoxide through the
suspension, and unexpectedly observed a prominent
optical absorption peak appearing at 450nm. This
strange carbon monoxide diﬀerence spectrum of the
liver microsomes (Fig. 1) showed no resemblance to
any of the known colored proteins including hemo-
proteins and copper proteins that could bind carbon
monoxide. He tried to examine the properties of the
novel pigment by solubilizing it from microsomes, but
various solubilization treatments always resulted in
complete disappearance of the 450nm spectrum.
Since the nature of the “microsomal carbon mon-
oxide-binding pigment” was not clear, the publication
of his novel spectral observation was much delayed.
Klingenberg left the Chance’s laboratory in 1956,
and returned to Germany to work on a diﬀerent
research subject in the laboratory of T. Bücher at
the University of München. Klingenberg’s work was
published in 19582) accompanied by a paper by D.
Garﬁnkel,22) who was also a postdoctoral fellow in the
Chance’s laboratory and conﬁrmed the Klingenberg’s
observations using pig liver microsomes. A short
paper written by Klingenberg describes the story of
his work in the Johnson Research Foundation during
1954–1956.23)
When Klingenberg was in the Johnson Research
Foundation, a visitor from Japan, R. Sato, and an
American postdoctoral fellow, R. W. Estabrook, were
also in the Chance’s laboratory. The three young
biochemists enjoyed friendly relation during their
stay in the same laboratory, and their acquaintance
happened to pave a way to the discovery of the
hemoprotein nature of “microsomal carbon monox-
ide-binding pigment” and its physiological function
as the oxygenase. Estabrook wrote a paper of his
T. OMURA [Vol. 87, 618remembrances of the early history of research on
P450, in which he describes the work of Klingenberg
at the Johnson Research Foundation.24)
Sato came back to Japan in 1954, and became
a professor of the newly established Institute for
Protein Research of the Osaka University, Osaka,
in 1959. As I heard from him, he was very much
interested in the mechanism of mitochondrial oxida-
tive phosphorylation, but he decided not to work
on mitochondria at his new laboratory because the
research on mitochondrial electron transport system
and oxidative phosphorylation was too keen in
competition by many laboratories worldwide. He
decided to work on a less competitive subject, non-
mitochondrial electron transport enzymes.
Sato invited me to join his new laboratory as
an assistant professor. I was studying plant laccase
in the Department of Chemistry of the Shizuoka
University, Shizuoka, at that time. Laccase is a
beautiful blue-colored protein puriﬁed from the latex
of Japanese lacquer tree (Rhus vernicifera). It was an
enjoyable subject of study for me, and I hesitated
to change my research subject. However, I ﬁnally
decided to accept Sato’s invitation to come to the
Institute for Protein Research to work on a new
research subject with him. I moved to Osaka in the
spring of 1960, and had intensive discussion with
Sato concerning my new research subject. He
suggested to me several possible research subjects,
among which was Klingenberg’s “microsomal carbon
monoxide-binding pigment”. He said, “Nothing is
known about the nature of this curious pigment in
liver microsomes, and, as far as I know, nobody is
currently working on it. Since it is reducible by
NADH and NADPH, it may have some function in
cellular respiration.” I read the papers by Klingenberg
and Garﬁnkel, and decided to work on this curious
pigment in liver microsomes.
I started my new work by repeating the experi-
ments described in Klingenberg’s paper2) using rabbit
liver microsomes instead of rat liver microsomes used
by Klingenberg, and fortunately I could soon make a
breakthrough observation on the spectral properties
of the “carbon monoxide-binding pigment”. I added
deoxycholate to the suspension of rabbit liver micro-
somes reduced with dithionite in the presence of
carbon monoxide. The 450nm peak of the carbon
monoxide compound of the microsomal pigment
quickly disappeared as described by Klingenberg,
but, unexpectedly, a prominent new peak appeared
at 420nm in the carbon monoxide diﬀerence spec-
trum of the solubilized microsomes (Fig. 2). The new
420nm spectrum was apparently the spectrum of
a hemoprotein with ,-a n dO-bands in the longer
wavelength region, and was very similar to the
carbon monoxide diﬀerence spectrum of hemoglobin,
but I could rule out the contamination of hemoglobin
in the microsomal preparation used in the spectral
study. Since the 420nm peak was as high as the
original 450nm peak, the most likely possibility was
the conversion of the 450nm form of the microsomal
pigment to a new 420nm form. To distinguish the
Fig. 1. Carbon monoxide diﬀerence spectra of rat liver micro-
somes (Ref. 2). ----- Carbon monoxide with NADH reduction.
—— Carbon monoxide with dithionite reduction.
Fig. 2. Carbon monoxide diﬀerence spectra of dithionite-reduced
rabbit liver microsomes (A: P450) and dithionite-reduced
solubilized microsomes (B: P420) (Ref. 6).
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“P-420”. P is the abbreviation of “pigment”.
I tried to conﬁrm the conversion of P-450 to
P-420 by following the time course of the spectral
change. Since the conversion of P-450 to P-420 by the
solubilization of microsomes with detergents was too
rapid to follow the time course, I had recourse to the
use of phospholipase C of a snake venom. Digestion
of biomembranes with phospholipase C releases
lysophospholipids from the membrane phospholipids,
and causes gradual solubilization of the membranes.
The venom of the Japanese snake Habu (Trimer-
esurus ﬂavoviridis) was used, and it gave a perfect
result. The disappearance of the 450nm peak of the
carbon monoxide compound of P-450 by digesting
the microsomes with the snake venom was quantita-
tively paralleled the appearance of the 420nm peak of
P-420,6) which strongly suggested the hemoprotein
nature of the original “microsomal carbon monoxide-
binding pigment”. It was also found that the micro-
somal carbon monoxide-binding pigment could bind
ethyl isocyanide to give a diﬀerence spectrum
suggestive of the hemoprotein nature of the micro-
somal pigment.1) Sato was very happy about these
breakthrough observations, but he requested me to
provide more decisive evidence for the hemoprotein
nature of P-450.
Since P-420 was already solubilized from the
membrane, it was possible to purify it by conven-
tional puriﬁcation procedures. Although the puriﬁ-
cation was still partial, I could clearly separate P-420
from cytochrome b5 that could interfere with the
spectral observation of P-420. As shown in Fig. 3, the
absolute spectra of the partially puriﬁed P-420 were
characteristic of a b-type cytochrome, conﬁrming the
hemoprotein nature of P-450.1),5)–7) Determination of
the content of protoheme in the P-420 preparation
gave the molar extinction coeﬃcients of the spectra of
P-420, and the comparison of the carbon monoxide
diﬀerence spectra of P-450 and P-420 allowed the
calculation of the molar extinction coeﬃcient of the
450nm peak of P-450, 91mM!1cm!1, which made it
possible to quantitate P-450 from its carbon mon-
oxide-diﬀerence spectrum.5),6) This value is still used
today in determining the amounts of P450 in
biological samples. It was also found that the amounts
of protoheme in the microsomal preparations could
be accounted for by P450 and cytochrome b5.6)
I talked with Sato concerning the publication
of these novel observations, and we wrote a short
preliminary paper reporting the hemoprotein nature
of the microsomal carbon monoxide-binding pigment
and sent it to Journal of Biological Chemistry. To our
great pleasure, the paper was smoothly accepted for
publication, and it appeared on the April issue of the
journal in 1962.1) We also wrote another preliminary
report describing the properties of the solubilized
form, P-420, and sent it to Biochimica et Biophysica
Acta. It was accepted in December, 1962.5) We were
naturally very happy, and began writing two full
papers describing the details of our study on P450.
Then we were startled to ﬁnd a short paper by Y.
Hashimoto, T. Yamano, and H. S. Mason25) appeared
in the December issue of Journal of Biological
Chemistry. The paper reported the discovery of a
novel iron protein in rabbit liver microsomes that
gave a unique electron spin resonance signal in the
oxidized form. The signal disappeared upon the
reduction of the microsomes by NADH or NADPH,
and the reduction was stimulated by carbon mon-
oxide indicating the carbon monoxide-binding prop-
erty of the protein. They gave a tentative name
“microsomal Fex” to this novel iron-containing
protein. It was apparent for us that microsmal Fex
was the same with P450. Hashimoto and Yamano
were visitors to the Mason’s laboratory from Japan.
The paper on “microsomal Fex” was a big
surprise for me, but I was happy to ﬁnd the name
H. S. Mason among the authors of the paper. Mason
was famous for his studies on copper enzymes
including mushroom laccase and phenolase. I con-
tacted him while I was studying plant laccase at the
Shizuoka University, and he gave me a kind response.
I had great respect to him as a leading scientist in
the same ﬁeld of research, biochemistry of copper
enzymes. I unexpectedly came across his path again.
Fig. 3. Absorption spectra of P420 partially puriﬁed from
solubilized rabbit liver microsomes (Ref. 7). —— oxidized form.
-----dithionite-reduced form.
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and sent them to Journal of Biological Chemistry in
the end of 1962, but the response from the journal
was disappointing. The two manuscripts were not
accepted, and were returned to us with many critical
comments. Some more experiments were apparently
needed to answer the comments. I spent several
months to prepare new experimental data to revise
the papers, and we sent the revised manuscripts to
the journal. They were again returned to us with
some more comments, and we had to revise the
papers once more spending a few months. They were
ﬁnally accepted, and appeared on the April issue of
the journal in 1964.6),7)
Mason and his collaborators continued their
study on “microsomal Fex”. They showed that the
spectral conversion of P450 to P420 by detergent
treatment was accompanied by the change of Fex
from its low spin state to high spin state.26) The ESR
measurement of microsomes could determine the
amount of Fex in the oxidized form, whereas the
spectrophotometry of the carbon monoxide com-
pound of P450 measured its reduced form. Yamano
came back to Japan from Mason’s laboratory in 1964
to become professor of the Osaka University, Osaka,
and continued his ESR study on microsomal Fex.
The identity of microsomal Fex with P450 was
conﬁrmed by Y. Ichikawa and T. Yamano in 1967.27)
Monooxgenase activity of cytochrome P450
It was fortunate that the physiological function
of P450 was soon found after its hemoprotein nature
had been elucidated. The breakthrough discovery
was reported in 1963 by R. W. Estabrook, D. Y.
Cooper, and O. Rosenthal of the University of
Pennsylvania, Philadelphia.3),4) Cooper was a sur-
geon. He was working with Rosenthal, who was
Professor of Biochemistry in Research Surgery at the
Harrison Department of Surgical Research, to inves-
tigate the relation between hypertension and the
regulation of steroid hormone biosynthesis in the
adrenal gland. His study was diﬃcult, however,
because the nature of the enzymes involved in the
biosynthesis of steroid hormones was unknown at
that time. Cooper asked Estabrook of the Johnson
Research Foundation in the same university to
support his study by giving advice on spectrophoto-
metric experiments.
In 1961, the 5th Congress of the International
Union of Biochemistry was held in Moscow. Sato
attended the Congress, and presented our novel
observation, the hemoprotein nature of “microsomal
carbon monoxide-binding pigment” at the meeting.
Estabrook and Klingenberg were also attending the
Congress. They met together and were happy to
renew their old friendship. Sato came back to Osaka
after the Congress, and told me “To my great
pleasure, Ron (Estabrook) and Martin (Klingenberg)
evaluated our work highly. In particular, Ron was
very much interested in the hemoprotein nature
of P450. It is understandable. He is an expert in
peroxidase.” The information that the Klingenberg’s
“microsomal carbon monoxide-binding pigment” is a
hemoprotein might have given Estabrook some idea
regarding the nature of the steroid hydroxylase of
adrenal cortex microsomes. Strong inhibition of the
steroid hydroxylase activity of adrenal cortex micro-
somes by carbon monoxide had already been reported
by K. J. Ryan and L. L. Engel in 1957.28) They
also noticed that the inhibition of the hydroxylase
activity by carbon monoxide was partially reversed
by the irradiation with white light, and suggested
possible involvement of some hemoprotein in the
hydroxylation reaction.28)
Estabrook and Cooper measured the carbon
monoxide diﬀerence spectrum of adrenal cortex
microsomes, and found P450 in the microsomes.
They then constructed a simple homemade optical
instrument to measure the photochemical action
spectrum of the light reversal of the carbon monoxide
inhibition of the steroid hydroxylation by bovine
adrenal cortex microsomes. The light reversal of the
carbon monoxide inhibition of the microsomes-
catalyzed C-21 hydroxylation of 17-hydroxyproges-
terone was analyzed.3) As shown in Fig. 4, the
photochemical action spectrum showed a broad peak
at around 450nm, indicating the involvement of
P450 in the hydroxylation reaction. They determined
the eﬀect of the carbon monoxide to oxygen ratio on
the hydroxylation reaction, and conﬁrmed the com-
petition of carbon monoxide with oxygen for the
hydroxylation reaction. Based on these observations
they concluded that P450 is involved in the steroid
hydroxylation reaction catalyzed by adrenal cortex
microsomes, and that P450 is the oxygenase that
activates molecular oxygen for the hydroxylation
reaction.3),4) They also conﬁrmed the participation of
P450 in the oxidative metabolism of various drugs
by liver microsomes using the same photochemical
action spectrum method, and reported it in 1965.29) A
story of their study is described in a paper written by
Cooper in 1973.30) Estabrook also wrote a chapter
for a book in 1996 describing the discovery of the
function of P450.31)
Early years of cytochrome P450 research No. 10] 621The ﬁndings that the biosynthesis of steroid
hormones in the adrenal gland and the oxidative
metabolism of drugs in the liver are both catalyzed
by P450 attracted much attention of the biochemists
working on these physiologically important metabolic
reactions. Many of them rushed into the research
on P450, and the photochemical action spectrum
method was widely utilized to conﬁrm the partic-
ipation of P450 in various metabolic reactions.
Wide distribution of cytochrome P450
among various organisms
P450 was originally found in the microsomes
from animal livers,1),2) and its presence in mitochon-
dria was soon discovered by B. W. Harding, et al. in
1964.32) They were studying the synthesis of steroid
hormones in the adrenal gland, and detected the
presence of P450 in the mitochondrial fraction
prepared from rat adrenal glands. Later studies by
other groups conﬁrmed the presence of P450 in the
mitochondria of various animal tissues including liver
and kidney.
P450 was found in the yeast Saccharomyces
cerevisiae by A. Lindenmayer and L. Smith in
1964.33) They detected P450 in the cell-free extracts
of the yeast cells from its carbon monoxide-diﬀerence
spectrum, but the physiological function of P450 in
the yeast was not clear at that time. Presence of P450
in the fungus Cunninghamella bainieri was suggested
by J. P. Ferris, et al. in 1973.34) The fungus mycelia
showed NADPH-dependent oxygenase activities to
several chemical compounds including aniline, naph-
thalene, etc., and the activities were inhibited by
carbon monoxide, although the spectral conﬁrmation
of P450 in the mycelial extract was not successful.
Later studies by other groups conﬁrmed the presence
of P450 in various ﬁlamentous fungi.
The ﬁrst bacterial P450 was found in the
bacteroids of nitrogen-ﬁxing Rhizobium by C. A.
Appleby in 1967.35) The Rhizobium P450 was
apparently soluble, and was partially puriﬁed from
the supernatant of the homogenates of the bacte-
roids. However, the function of the P450 in the
metabolism of Rhizobium was not elucidated. In the
next year, 1968, another bacterial P450 was reported
by M. Katagiri, B. N. Ganguli, and I. C. Gunsalus.36)
They were studying the hydroxylation of camphor by
Pseudomonas putida grown in a medium containing
camphor, and obtained a soluble extract from the
bacterial cells that catalyzed the NADH-dependent
hydroxylation of camphor. The extract was sepa-
rated into three fractions, one of which was P450. In
the same year, one more bacterial P450 was reported
by G. Cardini and P. Jurtshuk.37) The sonic extract
of Corynebacterium sp. Strain 7E1C grown in a
medium containing n-octane as the sole source of
carbon and energy catalyzed NADH-dependent
oxidation of n-octane to 1-octanol and octanoic acid.
The extract contained a soluble P450, which was
converted to P420 by the treatment with deoxycho-
late. The P. putida P450 was puriﬁed to homogeneity
and crystallized in 1970.38),39) This was the ﬁrst
puriﬁed preparation of P450, which was widely
utilized in the following years for studying the
molecular properties of P450 and the mechanism of
P450-catalyzed oxygenation reactions.
The ﬁrst report on the presence of P450 in plants
was published by P. J. Murphy and C. A. West in
1969.40) They studied the NADPH-dependent hy-
droxylation of kaurene by the microsomal fraction
from the endosperms of Echinocystis macrocarpa,
and found P450 in the microsomes from its character-
istic carbon monoxide diﬀerence spectrum. The
hydroxylation reaction was inhibited by carbon
monoxide, and the photochemical action spectrum
of the light reversal of the carbon monoxide
inhibition conﬁrmed the participation of P450 in
the hydroxylation reaction. Presence of P450 in the
microsomes from various plant tissues was reported a
few years later; the seedlings of Vinca rosea,41) the
endosperms of caster bean,42) the etiolated seedlings
of sorghum, etc.43)
By the end of the 1960s, wide distribution of
P450 among animals, plants, fungi, and bacteria was
Fig. 4. Photochemical action spectrum for the light reversal of
carbon monoxide inhibition of steroid C21 hydroxylase activity
of bovine adrenal cortex microsomes (Ref. 3).
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report describing the presence of P450 in the archaeon
Sulfolobus solfataricus by R. L. Wright et al. in
199644) ﬁnally conﬁrmed the universal distribution of
P450 among all of the ﬁve kingdoms of life.
Induction of drug-metabolizing cytochrome P450
in animal liver by drug administration
Since the conﬁrmation of the NADPH-depend-
ent oxidative metabolism of various drugs by liver
microsomes in 1955,21) the drug metabolism in animal
liver was actively studied in the latter half of the
1950s, and an interesting ﬁnding that the hepatic
drug metabolizing activity was induced by the
administration of certain chemical compounds was
reported by A. H. Conney et al. in 1956.45) They
found that the N-demethylation and the azo linkage
reduction of 3-methyl-4-monomethylaminoazoben-
zene by rat liver homogenate were greatly stimulated
by the intraperitoneal injection of certain polycyclic
aromatic hydrocarbons including 3-methylcholan-
threne to the animals. They reported in the next
year, 1957, the induction of liver microsomal
NADPH-dependent benzopyrene hydroxylase activ-
ity by the administration of benzopyrene or some
other polycyclic aromatic hydrocarbons to rats.46)
Various drugs including barbiturates were then
found to induce the microsomal drug-metabolizing
activities in the livers of the treated animals by H.
Remmer in 1959,47) by A. H. Conney, et al. in 1960,48)
and also by R. Kato in 1960.49) H. Remmer and H. J.
Merker reported in 1963 signiﬁcant proliferation of
endoplasmic reticulum in the hepatocytes of pheno-
barbital-treated rats in addition to an increase of the
drug metabolizing activity in the liver.50) Discovery
of the principal role of P450 in the oxidative
metabolism of drugs by liver microsomes in 196529)
prompted the investigation of the induction of
hepatic microsomal P450 by drugs. S. Orrenius, et al.
reported in 196551) that the phenobarbital-induced
increase of aminopyrine N-demethylation activity in
rat liver was accompanied by parallel increases of
microsomal P450 and NADPH-cytochrome c reduc-
tase activity. They also noticed remarkable prolifer-
ation of smooth endoplasmic reticulum in the
hepatocytes of the phenobarbital-treated animals.
I was in the laboratory of P. Siekevitz at the
Rockefeller University in the middle of the 1960s
studying the biosynthesis of microsomal membrane
proteins. Siekevitz and I were interested in the
induction of speciﬁc microsomal proteins accompa-
nied by remarkable proliferation of smooth endo-
plasmic reticulum in the hepatocytes by drug
administration, and we examined the eﬀects of
phenobarbital on the synthesis and turnover of
cytochrome b5 and NADPH-cytochrome c reductase
in the livers of the treated animals. I continued this
study after returning to the Institute for Protein
Research, Osaka University, in 1966 together with a
young collaborator, Y. Kuriyama. We found that the
rates of synthesis of these two microsomal proteins
were stimulated, and the turnover of NADPH-
cytochrome c reductase was prevented by the
administration of phenobarbital, resulting in a
signiﬁcant increase of the content of the reductase
in the microsomes (Y. Kuriyama, et al., 1969).52)
H. Jick and L. Shuster53) also reported the eﬀect
of phenobarbital on the turnover of microsomal
NADPH-cytochrome c reductase in mouse liver.
Although the puriﬁcation and characterization
of microsomal P450 was not yet possible in the latter
half of the 1960s, studies on the induction of hepatic
metabolism of various drugs by the administration of
several chemical inducers indicated possible presence
of multiple forms of P450 in the liver microsomes
of the treated animals. N. E. Sladek and G. J.
Mannering reported in 1966 that the ethylisocyanide
diﬀerence spectra of microsomal P450 in the livers
of 3-methylcholanthrene-treated rats were diﬀerent
from those of normal and phenobarbital-treated
animals.54) They concluded that the P450 induced
by 3-methylcholanthrene was diﬀerent from the P450
of normal and phenobarbital-treated rats. In the
next year, 1967, A. P. Alvares, et al. reported that
the induction by 3-methylcholanthrene resulted in a
shift of the maximum absorption peak of the carbon
monoxide compound of liver microsomal P450 from
450nm to 448nm, and proposed the presence of more
than one P450 in rat liver microsomes.55) However,
some other groups did not agree with such a view,
and proposed that liver microsomal P450 was
interconvertible between two spectrally diﬀerent
forms due to the binding of the chemical compounds
used in the induction (A. Hildebrandt, et al.,
1968),56) (J. B. Schenkman, et al., 1969).57) Y. Imai
and P. Siekevitz proposed that the hydrophobicity
around the heme of P450 was diﬀerent between the
microsomes of normal and 3-methylcholanthrene-
treated rats, which caused the observed diﬀerence
in the spectral properties of the same P450.58) The
former groups postulated the presence of multiple
molecular species of P450 in liver microsomes,
whereas the latter groups claimed the existence of
only one drug-metabolizing P450.
Early years of cytochrome P450 research No. 10] 623Intense controversy on this problem that had
lasted for several years in the latter half of the 1960s
came to an end when successful solubilization and
puriﬁcation of P450 from liver microsomes was
achieved in the middle of the 1970s. The P450
puriﬁed from the liver microsomes of phenobarbital-
treated rats was clearly diﬀerent from its counterpart
puriﬁed from the 3-methylcholanthrene-treated ani-
mals (D. Ryan, et al., 1975).59) Speciﬁc induction
of each of these two molecular species of P450 by
corresponding inducers was conﬁrmed by the use of
speciﬁc antibodies (P. E. Thomas, et al., 1979),60)
(N. Harada and T. Omura, 1981).61)
Selective induction of diﬀerent forms of P450
by various chemical compounds attracted much
attention. Regulation of steroidogenic P450s in the
steroidogenic organs by pituitary hormones was also
a hot subject of study. Successful cloning of the genes
of various forms of P450 in the 1980s enabled the
analysis of the structures of the genes and their
regulatory regions. Discovery of the participation of
several novel nuclear receptors including AhR in the
regulatiohn of drug-metabolizing P450s in 197662)
and Ad4BP in the regulation of steroidogenic P450s
in 199263) was the highlight of the intensive research
on the molecular mechanism of the regulation of
P450 genes in the following years.
Constitution of cytochrome
P450 enzyme systems
The monooxygenase activity of microsomal
P450 required the supply of reducing equivalents
from NADPH in addition to molecular oxygen. It was
therefore likely that some enzyme or enzyme system
is associated with P450 in the microsomes to supply
electrons from NADPH to P450. It was known that
the synthesis of steroid hormones from cholesterol
in the adrenal gland requires the monooxygenase
activities in both microsomes and mitochondria.
Since the presence of P450 in the mitochondria of
the adrenal gland was found by B. W. Harding, et al.
in 1964,32) participation of P450 in the steroid
hydroxylation reactions in mitochondria as well as
in microsomes was anticipated. It was also reasonable
to assume that the monooxygenase activity of
mitochondrial P450 was also dependent on the
supply of reducing equivalents from NADPH by
some electron transport enzyme in the mitochondria.
After the conﬁrmation of the monooxygenase activity
of P450, the constitutions of microsomal and
mitochondrial P450 enzyme systems were imminent
problems to be clariﬁed.
1) Mitochondrial P450 enzyme system.
After conﬁrming the role of P450 in the steroid
hydroxylation reactions of adrenal cortex micro-
somes, D. Y. Cooper and R. W. Estabrook wanted
to extend their study to mitochondrial steroid
hydroxylation reactions. However, the photochemical
action spectrum method, which worked nicely with
adrenal cortex microsomes,3) did not give satisfactory
results with the mitochondrial steroid hydroxylation
system. Meanwhile Estabrook invited me to spend a
year in his laboratory as a visiting scientist to work
with him on P450. I gladly accepted his invitation,
took a leave of absence from the Osaka University,
and came to Philadelphia in the summer of 1964.
Estabrook suggested to me working on the micro-
somal and mitochondrial P450s of the adrenal gland,
which was his collaborative research project with
Cooper at that time. I met Cooper, and he told me
that he recently prepared a “soluble” steroid hydrox-
ylase preparation from adrenal cortex mitochondria
by sonication. He gave me his solubilized mitochon-
drial preparation, and suggested to me trying the
puriﬁcation of the solubilized mitochondrial P450 to
conﬁrm its role in the steroid hydroxylation reac-
tions. I accepted his proposal, but I soon found that
the P450 in his preparation was not soluble. It was
associated with small membrane fragments that
could be sedimented completely by extensive ultra-
centrifugation. I was then surprised to ﬁnd that
the sedimented P450 was no longer reducible by
NADPH, whereas the P450 in the “solubilized”
mitochondrial preparation was rapidly reduced by
NADPH. The addition of the supernatant to the
sedimented P450 restored its reduction by NADPH.
It was apparent that the supernatant contained an
enzyme that transfers electrons from NADPH to the
membrane-bound P450.
Since the “P450-reducing enzyme” in the super-
natant was soluble, it was possible for me to purify it
by routine methods. Unexpectedly, it was clearly
separated into two fractions, a red and a yellow
fraction, by DEAE-cellulose chromatography. Nei-
ther of them alone was able to catalyze the reduction
of P450 by NADPH, but the P450 reducing activity
was restored when they were combined. The oxidized
and reduced spectra of the red fraction indicated it a
ferredoxin-type iron-sulfur protein. The yellow frac-
tion showed typical ﬂavoprotein spectra. Estabrook
and Cooper were highly excited by this novel
observation. Cooper quickly measured the deoxycor-
tisol 11O-hydroxylase activity of the separated
fractions, and conﬁrmed that both of the red and
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the hydroxylase activity with the membrane-bound
P450. We concluded that the electrons for the P450-
catalyzed steroid hydroxylation were transferred
from NADPH to mitochondrial P450 via a ﬂavopro-
tein and a ferredoxin-type iron sulfur protein. This
was the ﬁrst elucidation of the constitution of the
P450 enzyme systems.
We reported these novel ﬁndings at the sympo-
sium “Electron Transport Systems in Microsomes” of
the 49th Annual Meeting of the Federation of
American Societies for Experimental Biology held
in April 1965, in Atlantic City.64) The symposium
was organized by P. Siekevitz of the Rockefeller
Institute, New York. He gave an introductory talk
titled “Origin and functional nature of microsomes”65)
followed by P. Strittmatter and H. Kamin talking
about microsomal NADH-cytochrome b5 reductase
and NADPH-cytochrome c reductase, respectively.
H. S. Mason gave a talk on the metabolism of
“xenobiotics” by microsomal mixed-function oxidase.
L. Ernster reported the phenobarbital-induced in-
crease of microsomal drug oxidation activity in rat
liver. It was the ﬁrst meeting on the microsomal
electron transport system, and announced the start
of this new research ﬁeld. The full account of our
study on the P450 reductase system in adrenal cortex
mitochondria was published in 1966.66)
At about the same time, K. Suzuki and T.
Kimura at the College of Science, St Paul’s Univer-
sity, Tokyo, were also studying the steroid hydrox-
ylase of bovine adrenal cortex mitochondria. They
reported the isolation of an iron-sulfur protein from
the supernatant of the sonicated mitochondria in
1965, and named it “adrenodoxin”67). They also
reported the reduction of adrenodoxin by NADPH
catalyzed by a ﬂavoprotein in the supernatant.68)
Although they did not describe the role of adreno-
doxin in the mitochondrial P450-catalyzed steroid
hydroxylation reaction, the identity of adrenodoxin
with our ferredoxin-type iron-sulfur protein puriﬁed
from adrenal cortex mitochondria was apparent.
We were willing to accept their proposal to call
the mitochondrial iron-sulfur protein “adrenodoxin”.
Suzuki came to the Johnson Research Foundation
later to work with Estabrook after I left Philadelphia
in the summer of 1965 for New York to work with
P. Siekevitz in the Cell Biology Department of the
Rockefeller University.
I enjoyed my stay in Estabrook’s laboratory,
which made me interested in the biosynthesis of
steroid hormones. My later studies on the regulation
of steroidogenic P450s and the biogenesis of mito-
chondrial P450s were based on my experience during
my work with Estabrook and Cooper. I recently
wrote a short paper69) describing my research in the
Estabrook’s laboratory during 1964–1965.
2) Bacterial P450 enzyme systems. Un-
expectedly, a P450 reductase system similar to the
mitochondrial counterpart in its constitution was
found in a bacterium by M. Katagiri, B. N. Ganguli,
and I. C. Gunsalus in 1968.36) The NADH-dependent
camphor-hydroxylating system of Pseudomonas
putida was separated into three soluble components,
a soluble P450, an iron-sulfur protein, and a
ﬂavoprotein. The three components constitution of
the P. putida P450 system was apparently very
similar to the adrenal mitochondrial P450 system,
although the bacterial P450 was soluble and the
P450-catalyzed oxygenase reaction required NADH
in contrast to the NADPH-dependent animal mito-
chondrial P450 system. Katagiri was a visitor to the
Gunsalus’ laboratory from Japan. He returned to
Japan later to become professor of the Kanazawa
University, Kanazawa, and studied the steroid-
hydroxylating P450s of adrenal cortex in the follow-
ing years.
P. putida P450 system had remained the only
bacterial P450 system whose constitution had been
studied in detail until a few other bacterial P450
systems were found and characterized in the
1980s.70)–72) All of them were soluble systems similar
to the camphor hydroxylating P450 system of
Pseudomonas putida, and constituted of P450,
ferredoxin, and NADH-ferredoxin reductase.
3) Microsomal P450 enzyme system. Eluci-
dation of the constitution of the P450 enzyme system
in microsomes was diﬃcult because solubilization
treatments with detergents caused the conversion of
microsomal P450 to P420 resulting in the complete
loss of its oxygenase activity. The breakthrough
discovery to overcome this diﬃculty was made by Y.
Ichikawa and T. Yamano in 1967.73) They found the
stabilization of microsomal P450 against detergent
treatments by polyols including glycerol. Presence of
20–30% of glycerol in the suspension of liver micro-
somes allowed the solubilization of P450 by sodium
cholate without its conversion to P420. Reversal of
the PCMB-induced conversion of P450 to P420 by
GSH was also found. In the next year, 1968, A. Y. H.
Lu and M. J. Coon reported the successful solubiliza-
tion of the P450-catalyzed fatty acid B-hydroxylase
activity of rabbit liver microsmes by deoxycholate in
the presence of glycerol and DTT.74) They could
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fractions, a P450-containing fraction, an NADPH-
cytochrome c reductase-containing fraction, and an
unknown factor. The three fractions were necessary
to reconstitute the NADPH-dependent lauric acid B-
hydroxylase activity. Their ﬁnding suggested the role
of NADPH-cytochrome c reductase in the NADPH-
dependent P450-catalyzed oxygenation reactions of
microsomes. The unknown factor was later proved to
be phosphatidylcholine.75)
Solubilization and puriﬁcation of NADPH-cyto-
chrome c reductase from liver microsomes was ﬁrst
reported by C. H. Williams and H. Kamin,76) and
independently by A. H. Phillips and R. G. Langdon77)
in 1962. Williams and Kamin solubilized the reduc-
tase from microsomes by the treatment with pancre-
atic lipase, whereas Phillips and Langdon used
trypsin to solubilize the reductase. The solubilized
and puriﬁed reductase preparations contained FAD,
and retained the enzymatic activity of reducing
cytochrome c by NADPH. However, Y. Miyake,
J. L. Gaylor, and H. S. Mason reported in 1968 that
the reductase puriﬁed by the method of Williams and
Kamin was unable to reduce P450 by NADPH.78)
They prepared a particle fraction containing P450
from rabbit liver microsomes by treating the micro-
somes with Lubrol WX in the presence of glycerol.
NADPH-cytochrome c reductase and cytochrome
b5 were removed from the particle fraction by the
Lubrol treatment, and the particle-bound P450 was
no longer reducible with NADPH. The addition of
partially puriﬁed NADPH-cytochrome c reductase to
the particle fraction did not restore the reducibility
of P450 by NADPH. A. Y. H. Lu et al. also reported
in 1969 the inability of the NADPH-cytochrome c
reductase puriﬁed by the method of Williams and
Kamin to reconstitute the B-hydroxylation activity
when added to the P450-containing fraction solubi-
lized from rabbit liver microsomes by cholate.79) More
study was apparently needed to conﬁrm the role of
microsomal NADPH-cytochrome c reductase in the
transfer of electrons from NADPH to P450.
An important clue to solve this problem was
provided by A. Ito and R. Sato who reported the
solubilization and puriﬁcation of cytochrome b5
from liver microsomes by detergent treatment in
1968.80) Puriﬁcation of microsomal cytochrome b5
had already been reported by P. Strittmatter and
S. F. Velick in 1956.81) They solubilized the
cytochrome from rabbit liver microsomes by the
digestion with pancreatic lipase, and puriﬁed it to
homogeneity. They also reported the puriﬁcation of
NADH-cytochrome b5 reductase solubilized from
rabbit liver microsomes by lipase treatment in
1956,82) and also by the treatment with the venom
of the snake Naja naja in 1957.83) Pancreatic lipase
and the snake venom were supposed to decompose
the phospholipids of the microsomal membrane by
lipase and phospholipase activity, respectively, to
release cytochrome b5 and NADH-cytochrome b5
reductase from the membrane. However, the enzymes
responsible for the solubilization of these membrane-
bound proteins were not clearly identiﬁed.
Ito was a graduate student studying in the
Sato’s laboratory at the Institute for Protein
Research, Osaka University, and the aim of his study
was to elucidate the molecular mechanism of release
of cytochrome b5 from microsomal membrane by
various solubilization treatments. Ito started his
graduate study in 1963. I came back to the Sato’s
laboratory in 1966 from two years’ stay in America. I
studied the biosynthesis and turnover of microsomal
NADPH-cytochrome c reductase and cytochrome b5
in rat liver84) when I spent one year in the laboratory
of P. Siekevitz, who was intensively studying the
mechanism of biogenesis of membrane structures
in the cells. Since the state of binding of protein
molecules to the membrane is essential information
for the elucidation of the molecular mechanism
of formation of biomembranes, I was very much
interested in Ito’s study on the solubilization of
cytochrome b5 from microsomes by various treat-
ments. At the same time, Masahiko Negishi, who was
also a graduate student in the Sato’s laboratory, was
working with me on the biosynthesis of cytochrome
b5.85) Yoshiaki Kuriyama, who was a visitor from a
pharmaceutical company, was also working with
me in the Sato’s laboratory on the biosynthesis
of NADPH-cytochrome c reductase.52),86) We were all
interested in the structure of microsomal membrane,
and we often discussed together the molecular
mechanism of binding of microsomal proteins to the
membrane structure.
Ito worked hard and puriﬁed cytochrome b5
solubilized from rabbit liver microsomes by the
treatment with a neutral detergent, Triton X-100,
and examined the properties of the detergent-
solubilized cytochrome b5. Interestingly, the molecu-
lar weight of the detergent-solubilized cytochrome b5
determined by gel ﬁltration was larger than that of
the trypsin-solubilized counterpart. He concluded
that the detergent-solubilized cytochrome b5, whose
molecular weight was 25,000, was the native mem-
brane-bound form, whereas the trypsin-solubilized
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a proteolytic fragment of the native form. The former
was named detergent b5 or d-b5 to distinguish it from
the trypsin-solubilized form, trypsin-b5 or t-b5. It was
also found that d-b5 formed an oligomer in aqueous
solutions. Ito proposed that the native cytochrome b5
molecule is amphipathic, and anchors to the mem-
brane by the hydrophobic portion of the molecule,
which is split oﬀ from the hydrophilic heme-contain-
ing portion of the native molecule when the micro-
somes are treated with trypsin, forming water-soluble
t-b5.80) It was therefore highly likely that the solu-
bilization of NADPH-cytochrome c reductase and
cytochrome b5 by “lipase” reported previously76),81)
was actually due to some proteolytic activity,
possibly the activity of trypsin and/or chymotrypsin,
in the lipase preparation. S. Takesue and T. Omura
re-examined the solubilization of NADH-cytochome
b5 reductase from rat liver microsomes by Naja naja
venom reported before by P. Strittmatter and S. F.
Velick,83) and found that the lysosomal proteases
contaminated in the microsomal preparation, not the
phospholipases in the venom, were mainly respon-
sible for the solubilization of the reductase.87)
Conﬁrmation of the amphipathic nature of mem-
brane proteins was one of the important bases for the
formulation of the “ﬂuid-mosaic model” of biomem-
branes by S. J. Singer and G. L. Nicolson in 1972.88)
After Ito’s study of the puriﬁcation of detergent-
solubilized cytochrome b5, solubilization and puriﬁ-
cation of other microsomal proteins including
NADPH-cytochrome c reductase by the use of
detergents were attempted by many other research-
ers studying the microsomal P450 enzyme system. K.
Ichihara, E. Kusunose, and M. Kusunose reported
successful puriﬁcation of NADPH-cytochrome c
reductase solubilized from pig liver microsomes by
Triton X-100 in 1973.89) The puriﬁed reductase could
reconstitute fatty acid B-hydroxylase activity when
added to a partially puriﬁed detergent-solubilized
P450. Although the puriﬁcation of microsomal
P450 was yet to be achieved at that time, similar
reconstitution experiments by various groups in
the beginning of the 1970’s conﬁrmed the role of
NADPH-cytochrome c reductase in the supply of
electrons from NADPH to microsomal P450 for the
P450-catalyzed oxygenase reactions.90)–92)
Another approach to conﬁrm the role of
NADPH-cytochrome c reductase in the transfer of
electrons from NADPH to microsomal P450 was the
use of the inhibitory antibodies raised to the trypsin-
solubilized and puriﬁed reductase. When I came back
to Osaka in 1966, I started the preparation of rabbit
antibodies to NADPH-cytochrome c reductase and
cytochrome b5. My original purpose was to use the
antibodies to study the biosynthesis of those enzymes
by immunoprecipitation, but I soon found that the
antibody to NADPH-cytochrome c reductase eﬀec-
tively inhibited the NADPH-dependent P450-cata-
lyzed oxygenation reactions of microsomes. I re-
ported the observation at the “Microsomes and Drug
Oxidations Symposium” held in 1968 in Bethesda.93)
Similar studies using the antibodies to puriﬁed
NADPH-cytochrome c reductase were carried out
in the following years to elucidate the role of the
reductase in the transfer of electrons from NADPH
to P450 in microsomes (B. S. S. Masters, et al.,i n
1971).94) Since the function of NADPH-cytochrome
c reductase in the reduction of P450 by NADPH
was thus conﬁrmed, it became customary to call
it NADPH-cytochrome P450 reductase instead of
NADPH-cytochrome c reductase.
One more important development in the study
of NADPH-cytochrome c reductase in the beginning
of the 1970s was the ﬁnding by T. Iyanagi and H. S.
Mason in 1973 that the reductase contains both FMN
and FAD in equimolar amounts.95) Since previous
papers by other groups76),77) reported the presence of
only FAD in the puriﬁed reductase preparations, the
presence of FMN in NADPH-cytochrome c reductase
was an unexpected and highly important ﬁnding.
The oxidation-reduction of the FAD and FMN
prosthetic groups in the reductase molecule was
studied in detail, and provided important informa-
tion for the molecular mechanism of the transfer of
electrons from NADPH to P450.95),96) The FAD
receives electrons from NADPH, and then transfers
them to the FMN in the reductase molecule.
Cytochrome c receives electrons from FAD, whereas
P450 receives them from FMN. Iyanagi was visiting
the Mason’s laboratory from Japan, and came back
later to the Tsukuba University, Tsukuba, to
continue his study on NADPH-P450 reductase.
Although NADPH-P450 reductase, an NADPH-
speciﬁc ﬂavoprotein, was thus proved to be an
essential component of the microsomal P450 system,
stimulation of microsomal NADPH-dependent oxy-
genase activity by NADH was found by B. S. Cohen
and R. W. Estabrook in 1971.97) This phenomenon
was called “NADH-synergism”, and suggested the
contribution of some NADH-linked component to the
microsomal P450-dependent oxygenase activity. A.
Hildebrandt and R. W. Estabrook proposed the
contribution of cytochrome b5 to the electron transfer
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Their proposal was based on the observation that a
drug substrate lowered the steady state of reduction
of cytochrome b5 when NADH was included in the
NADPH-containing reaction medium. Later studies
by other groups conﬁrmed the NADH-synergism.
The NADH-synergism was observed not only with
microsomes but also with the reconstituted systems
containing d-b5 in addition to P450 and NADPH-
P450 reductase, and the extent of stimulation of the
NADPH-supported oxygenation activities of liver
microsomes by NADH was found to be signiﬁcantly
depending on the P450 species used (A. Y. H. Lu,
et al., 1974).99) Some P450 showed almost obligatory
requirement for cytochrome b5 for the drug oxidation
in the presence of NADPH and NADH (T. Sugiyama,
et al., 1979).100) Y. Imai and R. Sato studied the role
of cytochrome b5 in the NADPH-dependent drug
oxidation reaction using a reconstituted system in
1977, and found that cytochrome b5 supplied the
second electron to P450 and improved the coupling of
NADPH oxidation with the drug oxidation.101)
In addition to the researches with reconstituted
systems, use of inhibitory antibodies to cytochrome
b5 contributed to the elucidation of the role of
cytochrome b5 in the electron transfer from NADH
to P450 in intact microsomes. G. J. Mannering, S.
Kuwahara, and T. Omura reported in 1974 strong
inhibition of the NADH-synergism in the N-deme-
thylation of ethylmorphine catalyzed by rat liver
microsomes by rabbit antibodies raised to trypsin-
solubilized rat cytochrome b5.102) Mannering was very
much interested in the use of inhibitory antibodies in
studying the mechanism of electron transfer from
NADPH and NADH to P450 in the microsomal drug
oxidation reactions. He visited my laboratory at
the Kyushu University, Fukuoka, to spend several
months in 1973. Kuwahara was a graduate student
in my laboratory, and worked with Mannering.
M. Noshiro, V. Ullrich, and T. Omura analyzed
the NAD(P)H-linked reduction of microsomal P450
in 1981 by using the rabbit antibodies to cytochrome
b5, and concluded that the ﬁrst electron for the
reduction of ferric iron of the heme of P450 comes
from NADPH via NADPH-P450 reductase whereas
the second electron for the reduction of the oxy-
genated form of ferrous P450 may come either from
NADPH via NADPH-P450 reductase or from NADH
via cytochrome b5.103) Noshiro was a graduate
student in my laboratory at the Kyushu University.
He studied the pathways of electron transfer from
NADH and NADPH to cytochrome P450 in micro-
somes by the use of antibodies to cytochrome b5 and
NADPH-cytochrome c reductase (M. Noshiro, et al.,
1980),104) and then visited the Ullrich’s laboratory at
the University of Saarland, Germany, to study the
role of cytochrome b5 in the electron transfer from
NADH and NADPH to P450 in microsomes.
Some P450s seem to be highly dependent on
cytochrome b5 for the catalysis of NADPH-dependent
oxygenation of substrates, whereas some others
showed only slight dependence on cytochrome b5
(S. Kuwahara, and T. Omura, 1980).105) However,
some of more recent studies with reconstituted P450
systems showed that apo-cytochrome b5 is as eﬀective
as its holo-form in stimulating the NADPH-depend-
ent drug oxidation reactions, which seemed to deny
the role of cytochrome b5 in the electron transfer to
P450.106),107) It is generally agreed that cytochrome b5
contributes to the NADPH-dependent oxygenation
reactions catalyzed by microsomal P450s, in partic-
ular to the stimulation of the reactions by NADH,
but the molecular mechanism of its contribution to
the reactions are not yet clearly understood.
4) P450-reductase fusion proteins. In
addition to the soluble P450 enzyme systems
discovered in the 1960s, soluble P450-reductase
fusion proteins were also found in bacteria. The ﬁrst
of such catalytically self-suﬃcient P450 enzyme was
reported by L. O. Narhi and A. J. Fulco in 1986,
and named P450 BM-3.108) It was a fusion protein
consisting of a P450 domain and an NADPH-linked
P450 reductase domain, and catalyzed NADPH-
dependent B-2 hydroxylation of fatty acids.109) The
reductase domain contained both FAD and FMN,
and was very similar to animal NADPH-P450
reductase. Similar P450-reductase fusion proteins
were later found in some other bacteria and fungi,
and other P450-reductase fusion proteins of diﬀerent
types have recently been found in bacteria.
The four types of P450 enzyme systems were
thus found and characterized in the early years of
P450 research. Both microsomal and mitochondrial
P450 enzyme systems are present in animals, whereas
plants and fungi have only microsomal P450 enzyme
system. Soluble P450 enzyme system including P450-
reductase fusion proteins is found in prokaryotic
organisms. I recently wrote a review paper on the
structural diversity of P450 enzyme system.110)
Coordination state of the heme
of cytochrome P450
When the hemoprotein nature of the carbon
monoxide-binding pigment in liver microsomes was
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provoked intensive discussion about the coordination
state of the heme of P450. A remarkably big red shift
of the Soret peak of the carbon monoxide compound
of reduced P450 compared with known protoheme
hemoproteins, which had an imidazole group of
histidine as the axial ligand of the heme and showed
their Soret peaks at around 420nm when reduced
and ligated to carbon monoxide, suggested some
novel ligand coordinated to the axial position of the
heme of P450.
Contribution of sulfhydryl group to the
“abnormal” spectra of P450 was suggested by several
lines of evidence. K. Murakami and H. S. Mason
reported the conversion of low spin microsomal Fex
(P450) to its high spin form (P420) by sulfhydryl
reagents in 1967.26) Stabilization of microsomal P450
against its detergent-induced conversion to P420
by mercaptoethanol described by Y. Ichikawa and
T. Yamano in 196773) also suggested the role of
sulfhydryl group in the unique spectral properties of
P450. C. R. E. Jefcoate and J. L. Gaylor reported
in 1969 that the addition of n-propylmercaptan to
metmyoglobin converted the high-spin EPR spec-
trum of metmyoglobin to a low spin spectrum that
was almost superimposable with the EPR spectrum
of the low-spin form of P450.111) However, the
problem of the axial ligand that is responsible for
the unique 450nm optical absorption peak of the
carbon monoxide compound of ferrous P450 was not
clariﬁed.
Strong evidence for the mercaptide anion
(thiolate anion), possibly donated by a cysteine
residue of the P450 protein, as the ligand trans to
carbon monoxide in the carbon monoxide-compound
of reduced P450 was presented by J. O. Stern and J.
Peisach in 1974.112) They could prepare a model
compound that had the same optical peoperties in
the Soret and visible regions as the carbon monoxide
adduct of ferrous P450 by dissolving hemin chloride
and 2-mercaptoethanol in dimethylsulfoxide-ethanol
solvent in the presence of tetramethylammonium
hydroxide and carbon monoxide. Since the presence
of a thiol compound and a strong base was essential
for the appearance of the P450-type spectra, they
concluded that the axial ligand in the model com-
pound and also in the carbon monoxide adduct of
ferrous P450 is a mercaptide anion. This was the ﬁrst
successful preparation of a model compound that
reproduced the unique 450nm optical absorption
peak of the carbon monoxide compound of reduced
P450.
Concerning the cysteine residue that donates the
thiolate anion ligand to the heme, O. Gotoh et al.
compared the primary sequences of various cysteine-
containing portions in the primary sequences of
several microsomal and bacterial P450s, and sug-
gested in 1983 that a cysteine residue in the middle
of a short conserved segment near to the carboxy
terminus of those P450 molecules is the heme-binding
cysteine residue.113) Their prediction was conﬁrmed
in the next year, 1984, when the primary sequence of
a bovine mitochondrial P450, P450scc, was eluci-
dated by K. Morohashi, et al..114) Bovine P450scc
was found to contain only one cysteine residue in the
molecule, and the position of the cysteine residue
corresponded with the suggestion by O. Gotoh,
et al..113) Presence of a thiolate anion donated by
the cysteine residue at the 5th coordination position
of the heme of P450 was later conﬁrmed when the
X-ray crystallographic analysis of P450cam by T. L.
Poulos, et al. elucidated its tertiary structure in
1985.115)
I happened to be intimate with Peisach long
before he published his ﬁrst paper on P450, the paper
of the model compound, in 1974. He was interested in
the optical and EPR spectra of blue-colored copper
proteins in the beginning of the 1960s, and wanted to
study laccase. He noticed my papers on Japanese
lacquer tree (Rhus vernicifera) laccase published in
1961,116) and sent a letter to me asking me for the
supply of Japanese lacquer latex that was diﬃcult to
obtain in US. Since there were only a few biochemists
interested in plant laccase, I was very much happy to
hear of his interest in laccase, and supplied him with
the acetone powder of fresh lacquer latex in 1962.
We had an opportunity to meet together ﬁrst at a
symposium on copper proteins held at the Arden
House in Harriman State Park, New York, in
September 1965, when I was in the laboratory of P.
Siekevitz of the Rockefeller University. The sympo-
sium was organized by H. S. Mason, who kindly
invited me to come to the symposium. I was happy to
meet Peisach at the meeting, and we talked a lot
about laccase. When I saw his paper on the P450
model compound in 1974, I was amused to ﬁnd him
again interested in the same subject of research with
me, this time P450.
Reaction mechanism of cytochrome P450-
catalyzed oxygenation reactions
The monooxygenase reactions catalyzed by
P450 require one mole each of NADPH and molecu-
lar oxygen to oxygenate one mole of substrate.
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introduce one atom of oxygen to one molecule of the
substrate. Since the reduction of the ferric form
of P450 to the ferrous form, which can bind and
activate molecular oxygen, requires only one electron
(J. A. Peterson, et al., 1977),117) some reasonable
reaction mechanism had to be designed to deﬁne the
roles of the two electrons in the oxygenation reaction.
First clue for the elucidation of the reaction
mechanism was a spectral evidence for the speciﬁc
binding of the substrate to the oxidized form of P450.
S. Narasimhulu, D. Y. Cooper and O. Rosenthal
reported in 1965 that the addition of a steroid
substrate, 17-hydroxyprogesterone, to Triton-solubi-
lized adrenal cortex microsomes, which had P450-
catalyzed C-21 hydroxylase activity, gave a novel
diﬀerence spectrum with an absorption minimum at
420nm and a broad maximum at 390nm.118) The
diﬀerence spectrum disappeared when the substrate
was hydroxylated by the addition of NADPH.
Reduction of P450 by sodium dithionite also resulted
in the disappearance of the diﬀerence spectrum.
Non-substrate steroids did not show the diﬀerence
spectrum when added to the adrenal cortex micro-
somal P450 preparation. The same substrate-induced
diﬀerence spectrum was also observed when a
substrate, cortexone, was added to an adrenal cortex
mitochondrial preparation having P450-catalyzed
11O-hydroxylase activity (D. Y. Cooper, et al.,
1965).119) These observations suggested speciﬁc bind-
ing of substrates to the oxidized form of P450.
Similar substrate-induced spectral change was
observed with liver microsomal P450 by H. Remmer,
et al..120) and also by Y. Imai and R. Sato121) in the
next year, 1966. Several drug substrates of liver
microsomal P450, hexobarbital, aminopyrine, et al.,
induced the spectral change of P450 when added to
liver microsomes. J. B. Schenkman, H. Remmer, and
R. W. Estabrook analyzed the drug-induced spectral
change of liver microsomal P450 in 1967, and
identiﬁed three types of spectral change, Type I,
Type II and modiﬁed Type II spectral changes,
which seemed to be due to slight blue or red shift
of the Soret peak of the heme prosthetic group of
P450, depending on the drug substrates employed.122)
Since the concentration of a substrate necessary
for the half-maximal enzyme activity was similar to
the concentration of the same substrate necessary
for half-maximal spectral change, they concluded
that the binding of the substrate to the oxidized
form of P450 is an essential step of the oxygenation
reaction.
When Schenkman was studying the substrate-
induced spectral change of liver microsomal P450, I
was also in Estabrook’s laboratory. Schenkman was a
very pleasant person, and I enjoyed friendly relation
with him. He later visited Japan to spend one year in
Ryo Sato’s laboratory at the Institute for Protein
Research, Osaka University, in 1968–1969.123) I was
also in Sato’s laboratory at that time, and we were
happy to be together again.
Second important information for the mecha-
nism of the P450-catalyzed oxygenation reactions
was the spectral conﬁrmation of the existence of an
oxygenated form of reduced P450. R. W. Estabrook,
et al..124) and Y. Ishimura, et al..125) reported the
formation of a new spectral intermediate in the
oxygenation reaction catalyzed by liver microsomal
P450 and bacterial soluble P450cam, respectively, in
1971, and they concluded that the spectral inter-
mediate was the oxygenated form of reduced P450s.
Ishimura was visiting Estabrook’s laboratory from
Japan. He later came back to Japan to become
professor of the Medical School of the Keio Univer-
sity, Tokyo, and continued his study on P450.
Based on these lines of information, Estabrook
et al. proposed a scheme of electron transport
reactions associated with the oxygenation reaction
catalyzed by microsomal P450 in 1971.124) As shown
in Fig. 5, the scheme postulates the binding of a
substrate to the oxidized form of P450, and then the
reduction of the heme of P450 from ferric to ferrous
form by the supply of “ﬁrst” electron from NADPH-
P450 reductase. The reduced P450 binds oxygen to
form oxygenated compound, and the introduction of
“second” electron from cytochrome b5 or NADPH-
P450 reductase to the oxygenated P450 activates the
bound oxygen molecule resulting in the introduction
of one atom of oxygen to the substrate. Another atom
of oxygen is reduced to water, and P450 returns to
the original oxidized form to start another cycle
of the reaction. This scheme, which was originally
proposed in 1968,126) nicely explained the supply of
two electrons from NADPH to P450 in the P450-
catalyzed oxygenation of one molecule of the
substrate, and was widely accepted to explain various
observations on P450-catalyzed reactions in the
following years.
The oxidation-reduction potential of microsomal
P450 was ﬁrst measured by M. R. Waterman and
H. S. Mason in 1970.127) It was very low, !410mV.
The low redox potential of P450 was conﬁrmed
by later studies for liver microsomal P450 (M. R.
Waterman and H. S. Mason, 1972),128) (J. Ingledew,
T. OMURA [Vol. 87, 630et al., 1976),129) and for adrenal cortex mitochondrial
P450 (D. L. Williams-Smith and R. Cammack,
1977).130) It was also found that P450 exists in two
forms, low redox potential low spin form and high
redox potential high spin form. The former is a
substrate-free form, whereas the latter is substrate-
bound form.130) The elevation of the low redox
potential of P450 by substrate binding should make
the transfer of electrons from NADPH-P450 reduc-
tase easier. In the absence of a suitable substrate,
the reduction of P450 will be slower owing to its
low redox potential. The binding of a substrate to
oxidized form of P450 initiates the oxygenation
reaction, whereas the absence of a suitable substrate
will prevent the futile formation of the oxygenated
form of reduced P450 that will decay fruitlessly
forming noxious activated oxygen species.
An interesting novel type of the P450-catalyzed
oxygenation reaction, the peroxide-dependent oxy-
genation of various substrates, was found in 1975.
A. D. Rahintula and P. J. O’Brien reported P450-
catalyzed dealkylation of various drug substrates
when cumene hydroperoxide was added to liver
microsomes.131) Neither NADPH nor oxygen was
required, and the reaction was not inhibited by
carbon monoxide. E. G. Hrycay, et al. also reported
in the same year peroxide-dependent hydroxylation
of steroids by partially puriﬁed P450.132) Sodium
periodate, sodium chlorite, and hydrogen peroxide as
well as organic hydroperoxides could support the
P450-catalyzed hydroxylation reaction. The mech-
anism of peroxide-supported oxygenation reactions
catalyzed by P450 was studied by several groups in
the following years.
Formation of reactive intermediates in the P450-
catalyzed oxygenation reactions was another impor-
tant subject of research on the mechanism of the
oxygenation reactions in the 1970s. It was already
known since the 1950s that various carcinogenic
hydrocarbons bind covalently to DNA, RNA, and
proteins in the animal tissues. Since the carcinogenic
hydrocarbons, polycyclic aromatic hydrocarbons, are
not chemically reactive, they must be metabolically
activated in the cells to electrophilic compounds to
Fig. 5. A scheme of microsomal electron transport reactions associated with cytochrome P450 function during hydroxylation reactions
(Ref. 119). fpT: NADPH-cytochrome c reductase, fpD: NADH-cytochrome b5 reductase.
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their carcinogenic eﬀects.133) Various lines of evidence
including the migration of aryl ring substituents
(NIH shift) indicated that the epoxides, the arene
oxides, were the intermediates of the P450-catalyzed
hydroxylation of polycyclic aromatic hydrocarbons.
The formation of 1,2-naphthalene oxide as an
intermediate in the oxidative metabolism of naph-
thalene by liver microsomes to 1-naphthol was
conﬁrmed by D. M. Jerina, et al. in 1970.134) J. K.
Selkirk, et al. also reported in 1971 the formation of
an epoxide of a carcinogenic polycyclic aromatic
hydrocarbon, dibenzanthracene, by the metabolism
by liver microsomes.135) Metabolic activation of
carcinogenic polycyclic aromatic hydrocarbons by
liver microsomes was actively studied in the following
years, and the principal contribution of microsomal
P450 to chemical carcinogenesis was ﬁrmly estab-
lished.
Puriﬁcation of cytochrome P450
Puriﬁcation of P450 from microsomes and
mitochondria was naturally a major target of
biochemical research on P450 from the beginning,
but the conversion of P450 to the denatured inactive
form P420 by the treatment with detergents1),5) had
been a deadly obstacle to various trials to solubilize
and purify membrane-bound P450 in the 1960s. In
contrast, a soluble P450, P450cam, of the bacterium
Pseudomonas putida was puriﬁed to homogeneity in
1968.38)
The breakthrough discovery by Y. Ichikawa and
T. Yamano in 1967 that polyols like glycerol stabilize
membrane-bound P450 against detergent treat-
ments73) opened the way to successful solubilization
and puriﬁcation of P450s from microsomes and
mitochondria. Several papers reported partial puriﬁ-
cation of P450 from liver microsomes and adrenal
cortex mitochondria in the beginning of the
1970s,136)–139) followed by successful puriﬁcation of
several forms of microsomal and mitochondrial P450s
to homogeneity in the middle of the 1970s; from
rabbit liver microsomes by T. A. van der Hoeven,
et al.,140) by D. A. Haugen and M. J. Coon,141) and
also by Y. Imai and R. Sato,142) from rat liver
microsomes by D. Ryan, et al.,143) from mouse liver
microsomes by M. T. Huang, et al.,144) and by M.
Negishi and D. W. Nebert,145) from bovine adrenal
cortex mitochondria by S. Takemori, et al.,146),147)
from bovine adrenal cortex microsomes by S.
Kominami, et al.148) Since the induction of liver
microsomal P450 by chemical inducers greatly
increased the contents of speciﬁc forms of P450 in
the microsomes, phenobarbital-treated or 3-methyl-
cholanthrene-treated animals were used in the
puriﬁcation of P450s from liver microsomes. Poly-
chlorinated biphenyls (D. E. Ryan, et al.)149) and
tetrachlorodibenzo-p-dioxin (E. F. Johnson and U.
Muller-Eberhard)150) were also used to induce P450
in animal livers for puriﬁcation. Although the
puriﬁcation studies were mainly focused on mamma-
lian sources, puriﬁcation of P450 from yeast micro-
somes was achieved by Y. Yoshida et al. in 1977.151)
The homogeneity of the puriﬁed preparations was
usually assessed by SDS-polyacrylamide gel electro-
phoresis.
Puriﬁcation of distinct phenobarbital-inducible
and 3-methylcholanthrene-inducible forms of P450
from liver microsomes conﬁrmed the presence of
multiple forms of drug-metabolizing P450 in the
microsomes. They were diﬀerent in the molecular
weight determined from the mobility on the SDS-
polyacrylamide gel, and also in the substrate speciﬁc-
ity of their catalytic activities measured by the use of
reconstituted systems. The antibodies prepared to
each of phenobarbital-induced and 3-methylcholan-
threne-induced P450s could clearly distinguish the
two forms.
Presence of several other forms of P450 in liver
microsomes was found in the following years by
examining the induction of characteristic drug-
metabolizing activities by various inducers. Chronic
administration of ethanol to rats was found to induce
a novel form of P450 in the liver microsomes (J. P.
Villeneuve, et al., 1976).152) The eﬀect of pregneno-
lone-16,-carbonitrile administration to rats on the
drug-metabolizing activities of the liver microsomes
was explained by an induced increase of a new
form of P450 (N. A. Elshourbagy and P. S. Guzelian,
1980).153) The microsomal P450 induced by the
administration of isosafrole to rats was a new form
diﬀerent from either of 3-methylcholanthrene-indu-
cible and phenobarbital-inducible P450s (D. E. Ryan,
et al., 1980).154) Cloﬁbrate was found to induce a new
form of P450 in the liver of the treated rats (G. G.
Gibson, et al., 1982).155) Since the metabolism of
drugs in the liver was one of the major subjects of
research on P450 in the 1970s, puriﬁcation and
characterization of P450s from the liver microsomes
of drug-treated animals were intensively studied.
In addition to the diﬀerence in the molecular
weight determined by SDS-polyacrylamide gel elec-
trophoresis and in the substrate speciﬁcity of the
oxygenase activity measured with reconstituted
T. OMURA [Vol. 87, 632systems, diﬀerence in the amino-terminal amino acid
sequences determined by chemical sequencing of the
puriﬁed samples conﬁrmed the molecular distinction
of various P450 species (D. A. Haugen, et al.,
in 1977),156) (L. H. Botelho, et al., in 1979).157)
Ouchterlony double immunodiﬀusion test using the
antibodies raised to the puriﬁed P450 samples was
also utilized to conﬁrm the distinction of the puriﬁed
P450 species.
Availability of the antibodies speciﬁc to each of
the multiple forms of P450 enabled the detection of
these P450s in various animal tissues by immuno-
histochemical staining of the tissue slices using
optical microscopes and electron microscopes, and
conﬁrmed the presence of P450s in almost all tissues
examined including brain. Expression of steroid
hormone-synthesizing P450s in particular neurons
in various parts of animal brains attracted special
attention. Local production of steroid hormones, in
particular estrogens, in the brain suggested paracrine
or autocrine functions of the “neurosteroids”, which
has been actively studied in the following years.
Primary structures of cytochrome P450
When the puriﬁcation of microsomal and mito-
chondrial P450s was achieved, next target of research
was the determination of the complete amino acid
sequences of puriﬁed P450s. First successful elucida-
tion of the primary sequences of two P450s, a soluble
bacterial P450 and a liver microsomal P450, was
reported in 1982. The former, P450cam of Pseudo-
monas putida, was sequenced by chemical sequencing
by M. Haniu, et al.,158) whereas the primary sequence
of the latter, a phenobarbital-induced rat liver
microsomal P450, was deduced from the nucleotide
sequence of a cloned cDNA by Y. Fujii-Kuriyama
et al..159)
The use of a molecular biological technique,
cDNA cloning, greatly accelerated the elucidation of
the complete amino acid sequences of various P450s.
The primary sequences of many P450s were reported
in the 1980s, and the accumulation of the primary
sequence data necessitated a systematic classiﬁcation
of these 450s. Based on the similarity of the amino
acid sequences, P450s were classiﬁed into many
families and subfamilies, and the symbol “CYP” for
P450 genes was proposed by D. Nebert et al. in
1987.160) Comparison and analysis of the available
amino acid sequences of animal, plant, and bacterial
P450s led O. Gotoh and Y. Fujii-Kuriyama in 1989 to
the conclusion that all of their genes have evolved
from a single ancestral P450 gene,161) and the P450
genes of various organisms form one super gene
family.
In the following years, the genes of many
mammalian P450s were cloned and characterized,
and the molecular mechanisms of the regulation of
the expression of various P450 genes in the liver and
the adrenal cortex were intensively studied in the
1980s and the 1990s. Drug-induced increase of
particular P450s in the liver was the major focus of
the studies. The research on P450 shifted from
biochemical studies to molecular biological studies,
and expanded further.
Epilogue
Fifty years have passed since the ﬁrst paper on
“cytochrome P450” was published in 1962. Major
events in the research on P450 during the initial two
decades, the 1960s and the 1970s, are reviewed in this
paper. It was the ﬁrst stage of the research on P450 in
the times of traditional biochemistry, starting from
the characterization of P450 and P450-catalyzed
reactions followed by the puriﬁcation of many forms
of P450 from animal tissues, and ﬁnally the
elucidation of their primary structures. P450-cata-
lyzed metabolism of drugs in the liver and the role of
P450 in the biosynthesis of steroid hormones in
steroidogenic organs were actively studied. The role
of P450 in chemical carcinogenesis by polycyclic
aromatic hydrocarbons was also a major subject of
study.
Cloning of the cDNAs and the genes of various
P450s in the beginning of the 1980s opened the
second stage of P450 research. Expression of many
forms of P450 in various non-hepatic animal tissues
including brain, which had been diﬃcult to detect by
spectral observations, was elucidated by Northern
blotting and immunohistochemical staining, and
tissue-speciﬁc expression of various P450s and their
physiological functions were studied. Characteriza-
tion of P450 genes enabled the analysis of the
molecular mechanism of the regulation of expression
of the genes, which was the major focus of P450
research in the 1980s and the 1990s. These two
decades were the times of molecular biology of animal
P450s.
Elucidation of the total nucleotide sequence of
human genome in 2001 heralded a new age of biology
research. It was soon followed by the elucidation of
the genomes of various eukaryotic and prokaryotic
organisms, and the presence of many P450 genes in
animals, plants, and microorganisms was conﬁrmed
by the analysis of their genomes. It has now become
Early years of cytochrome P450 research No. 10] 633possible to study and compare the physiological
functions of P450s in various organisms of diﬀerent
kingdoms and phyla to elucidate the roles of P450s
in the evolution and diﬀerentiation of eukaryotic
organisms. We are now in the third stage of P450
research brighter than the previous two stages.
I wrote a short historical review titled “Forty
Years of Cytochrome P450” in 1999.162) I am happy
to see remarkable expansion of P450 research in the
past 10 years, and expect further progress in coming
years.
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